REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Historical Holders from Q1 2021 to Q1 2025

CUSIP
761330AB5
Type / Class
Debt / NOTE 1.750% 2/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
188M
Holdings value
$238M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
18
Number of buys
8
Number of sells
-12
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Period Principal Value Change Price Investors
2025 Q1 $0 $0 -$2.65M 0
2024 Q4 $188M $238M -$7.87M $0.96 18
2024 Q3 $198M $177M +$6.71M $0.85 22
2024 Q2 $212M $139M -$15.5M $0.66 21
2024 Q1 $236M $206M -$23.1B $0.73 24
2023 Q4 $279M $202M +$5.83M $0.76 24
2023 Q3 $260M $1.34B +$1.15B $0.81 30
2023 Q2 $231M $246M -$15.2M $1.06 27
2023 Q1 $240M $301M -$2.93B $1.23 27
2022 Q4 $234M $217M -$32M $0.92 23
2022 Q3 $308M $289M -$7.33M $1.09 26
2022 Q2 $273M $224M -$15.2M $0.81 17
2022 Q1 $249M $237M -$22M $0.94 18
2021 Q4 $252M $228M -$14.7M $0.88 18
2021 Q3 $282M $332M +$6.89M $1.15 21
2021 Q2 $262M $330M +$1.16M $1.17 25
2021 Q1 $266M $327M +$327M $1.12 27